Dr. Manyak’s presentations from 2004 to the current year of 2013

2011 thru 2013

Wharton School of Business, Postgraduate School of Executive Management. Expedition Medicine. Philadelphia, PA.
Future Direction in Urology Conference. Advances in Diagnostic Imaging: An Update. Greenbriar, West Virginia.
Exosome Board of Directors. Expedition Medicine. New York, NY.
Wharton School of Business, Postgraduate School of Executive Management. Off the Beaten Path. Philadelphia, PA.
GlaxoSmithKline Sexual Side Effects Advisory Board. Sexual Dysfunction with 5-ARI Use: Androgenic Alopecia. Miami, FL.
GlaxoSmithKline Canadian National Launch Meeting. Prostate Specific Antigen. Toronto, Canada.
GlaxoSmithKline Canadian National Launch Meeting. Expedition Medicine. Toronto, Canada.
National Eagle Scout 100th Anniversary Dinner. The Legacy of an Eagle: From Africa to the Antarctic. East Lansing, MI.
George Washington University Department of Engineering. Practical Applications of Engineering to Remote Medical Problems: Expedition Medicine. Washington, DC.
National Eagle Scout Explorers Club Reception. Exploration Beyond the Eagle Scouts. New York, NY.
Mexican Urological Society. Shedding New Light on PSA Clinical Utility. Mazatlan, Mexico.
GlaxoSmithKline Mexican National Launch Meeting. Safety Issues with 5-ARI Use. Cancun, Mexico.
GlaxoSmithKline Mexican National Speakers Bureau Meeting. Sexual Side Effects and BPH Medical Therapy. Cancun, Mexico.

2010

Detroit Urology Update. Molecular Risk Prediction for Prostate Cancer. Troy, MI.
Eastern VA Medical School. Visiting Professor. Advances in Bladder Cancer Tumor Markers. Norfolk, VA.
Eastern VA Medical School. Urology Grand Rounds. Molecular Risk Prediction for Prostate Cancer. Norfolk, VA.
International Prostate Cancer Update. Molecular Risk Prediction for Prostate Cancer. Vail, CO.
San Jose Urological Update. Molecular Risk Prediction for Prostate Cancer. San Jose, CA.
Medical University of South Carolina Grand Rounds. Molecular Risk Prediction for Prostate Cancer. Charleston, SC.
Seattle Prostate Institute Quarterly Update. Molecular Risk Prediction for Prostate Cancer. Seattle, WA.
Endo Pharmaceuticals Technology Seminar. Advances in Diagnosis and Treatment of Bladder Cancer. Chadd’s Ford, PA.
University of Kentucky Wilderness Medicine Interest Group. Expedtion Medicine: Taking the Risk Out of Adventure. Lexington, KY.
Cancer Centers of the Carolinas Tumor Board. Molecular Risk Prediction for Prostate Cancer. Greenville, SC.

2009

St. Joseph’s Hospital Tumor Board. Molecular Risk Prediction for Prostate Cancer. Baltimore, MD.
Prostate Cancer Update. AUA Western Section National Meeting. Risk Prediction for Prostate Cancer. Las Vegas, NV.
Birmingham Urological Society. Molecular Risk Prediction for Prostate Cancer. Birmingham, AL.
St. Joseph’s Hospital Urology Grand Rounds. Molecular Risk Prediction for Prostate Cancer. Baltimore, MD.
Urology Update. Risk Prediction for Prostate Cancer. Las Vegas, NV.
Hackensack Medical Center Urology Grand Rounds. Molecular Risk Prediction for Prostate Cancer. Hackensack, NJ.
Urology Update. Molecular Risk Prediction for Prostate Cancer. Oklahoma City, OK.
Urology Update. Molecular Risk Prediction for Prostate Cancer. Nashville, TN.
Seattle Prostate Institute. Searching for Prostate Cancer: The Evolution of Imaging. Seattle, WA.
Greensboro Urological Update. The Evolution of Imaging for Prostate Cancer. Greensbore, NC.
AUA National Conference, satellite symposium. Advances in the Role of Immunoscintigraphy for Prostate Cancer. Chicago, IL.
Urological Update. Searching for Prostate Cancer: The Evolution of Imaging. Augusta, GA.
Dallas Plano Urological Update. Searching for Prostate Cancer: The Evolution of Imaging. Dallas, TX.
Nevada Cancer Institute. Searching for Prostate Cancer: The Evolution of Imaging. Las Vegas, NV.
Indiana University Medical Center Tumor Board. The Evolution of Imaging for Prostate Cancer. Indianapolis, IN.
Miami Urological Update. Advances in Imaging Prostate Cancer. Miami, FL.
Christ Hospital Tumor Board. Searching for Prostate Cancer: The Evolution of Imaging. Chicago, IL.
Kaiser Permanente Tumor Board. The Evolution of Imaging for Prostate Cancer. Los Angeles, CA.
Desert Radiology Grand Rounds. The Evolution of Imaging for Prostate Cancer. Las Vegas, NV.
Cornell NY Hospital Grand Rounds. Searching for Prostate Cancer: The Evolution of Imaging. New York, NY.

2008

CMS HCPCS meeting. The Role of Caphosol in Treatment of Oral Mucositis. Baltimore, MD.
Canadian Prostate Cancer Research Foundation. The Evolution of Imaging for Prostate Cancer. Toronto, Canada.
Hackensack Department of Urology Grand Rounds. The Evolution of Imaging for Prostate Cancer. Hackensack, NJ.
Urology Update. The Evolution of Imaging for Prostate Cancer. Dallas, TX.
Tulane University Department of Urology Grand Rounds. The Evolution of Imaging for Prostate Cancer. New Orleans, LA.
Poconos Lake Preserve Speaker Series. The Titanic Salvage Expedition. Blakeslee, PA.
Masters in Urology Conference. The Evolution of Imaging for Prostate Cancer. Bermuda.
Masters in Urology Conference. Biomarkers for Bladder Cancer: An Update. Bermuda.
Expedition Medicine Conference. Taking the Risk Out of Adventure: Medical and Evacuation Insurance. Washington, DC.
Geisinger Medical Center Grand Rounds. The Evolution of Imaging for Prostate Cancer. Danville, PA.
Society of Nuclear Medicine, Eastern Chapter National Meeting. The Emerging Role of Immunoscintigraphy for Prostate Cancer. Niagara Falls, NY.
Rex Hospital Urological Update. The Evolution of Imaging for Prostate Cancer. Raleigh, NC.

2007

The Emerging Role of Imaging for Prostate Cancer. British Association of Urologic Surgeons, Genitourinary Oncology Annual Meeting. Bristol, England. November 16, 2007
The Current State of Bladder Tumor Markers. British Association of Urologic Surgeons, Genitourinary Oncology Annual Meeting. Bristol, England. November 14, 2007
The Evolution of Imaging for Prostate Cancer. Perspectives in Urology: Point-Counterpoint. Phoenix, AZ. November 9, 2007
Computer Recognition of Bladder Cancer with Optical Coherence Tomography and Texture Analysis. World Congress of Endourology. Cancun, Mexico. October 31, 2007
 Conducted postgraduate course at the American Academy of Family Practitioners. Expedition and Wilderness Medicine. Las Vegas, NV. October 27, 2007.
Advances in Imaging Prostate Cancer. University of Arkansas Cancer Research Center Tumor Board. Little Rock, AR. Sept 19, 2007.
 The Urology Perspective: Imaging Prostate Cancer. The 4th AdMeTech Foundation Conference. Washington, DC. Sept 17, 2007.
The Evolution of Imaging for Prostate Cancer. Karmanos Cancer Center Tumor Board, Detroit, MI.
Capromab Pendetide Imaging with Central Abdominal Uptake: Poor Prognosis for Prostate Cancer Patients. The American Urological Association Annual Meeting, Anaheim, CA.
Advances in Imaging: The Search for Prostate Cancer. University of Wisconsin Department of Urology Grand Rounds, Milwaukee, WI.
Clinical Implications for Immunoscintigraphy. Overreader Symposium, Society of Nuclear Medicine Annual Meeting, Washington, DC.
Expedition Medicine: An Emerging Discipline. SUNY Upstate, Syracuse, NY.
The Search for Prostate Cancer: Advances in Diagnostic Imaging. SUNY Upstate Urology Grand Rounds, Syracuse, NY.
The Evolution of Imaging for Prostate Cancer. US TOO Regional Prostate Cancer Support Group meeting, Datoli Prostate Cancer Center, Sarasota, FL.
The Evolution of Immunoscintigraphy for Imaging Prostate Cancer. Masters in Urology International Conference, Bermuda.
The Future of Imaging, Masters in Urology International Conference.Bermuda.
An Update on Bladder Cancer Tumor Markers. Masters in Urology International Conference, Bermuda.
Viking Systems National Sales Meeting. Advances in Diagnostic Imaging: The Fusion of Technology. Las Vegas, NV.
Engineering in the Americas. University of Miami International Conference. Biomedical Engineering and Imaging: The Wave of the Future. Coral Gables, FL.
Northwestern University Department of Urology Grand Rounds. The Evolution of Imaging for Prostate Cancer. Chicago, IL.
Urological Update. The Search for Prostate Cancer: Advances in Imaging. Atlanta, GA.
Baylor University Medical Center Department of Urology Grand Rounds. The Search for Prostate Cancer: The Role of Immunoscintigraphy. Houston, TX.
Wake Forest University Institute of Regenerative Medicine. Advances in Diagnosis with Molecular Imaging. Winston-Salem, NC.
Wake Forest University Department of Urology Grand Rounds. The Search for Prostate Cancer: Advances in Imaging. Winston-Salem, NC.
Urological Update. The Evolution of Imaging for Prostate Cancer. Cleveland, OH.
Memorial Sloan Kettering Cancer Center Prostate Cancer Working Group Grand Rounds. The Evolution of Imaging for Prostate Cancer. New York, NY.
Lahey Clinic Department of Urology Grand Rounds. The Search for Prostate Cancer: Advances in Diagnostic Imaging. Burlington, MA.
University of Arkansas Department of Urology Grand Rounds. The Evolution of Imaging for Prostate Cancer. Little Rock, AK.
Urological Update. The Evolution of Imaging for Prostate Cancer. Miami, FL.

2006

US TOO Prostate Cancer Support Group. Advances in Imaging for Prostate Cancer. Washington, DC.
16th International Prostate Cancer Update. The Evolution of Radioimmunoscintigraphy: Outcomes Data. Beaver Creek, CO.
12th Annual Paul C. Peters Urology Symposium. Advances in Imaging Prostate Cancer. Dallas, TX.
12th Annual Paul C. Peters Urology Symposium. Expedition Medicine: The Titanic Salvage Expedition. Dallas, TX.
Vanderbilt Department of Urology Grand Rounds. Advances in Imaging Prostate Cancer. Nashville, TN.
George Washington University Department of Urology Grand Rounds. The Evolution of Immunoscintigraphy for Prostate Cancer. Washington, DC.
Walter Reed Army Medical Center Department of Urology Grand Rounds.Advances in Diagnostic Imaging. Washington, DC.
Endocare National Sales Meeting. The Basics of Prostate Cancer. Newport Beach, CA.
University of Virginia Department of Urology Grand Rounds. The Evolution of Immunoscintigraphy for Imaging Prostate Cancer. Charlottesville, VA.
Sousa Middle School. Expedition Medicine and the Titanic Salvage Expedition. Washington, DC.
Walter Reed Army Medical Center Radiation Oncology Grand Rounds. The Role of Immunoscintigraphy for Imaging Prostate Cancer. Washington, DC.
George Washington University Biomedical Engineering Institute postgraduate course. Advances in Diagnostic Imaging. Washington, DC.
Society of Urologic Nurses Association. The Evolution of Radioimmunoscintigraphy for Imaging Prostate Cancer. Rochester, MN.
Minnesota Urological Association Annual Meeting. Advances in Diagnostic Imaging for Prostate Cancer. Minneapolis, MN.
University of North Carolina Department of Radiation Oncology. The Evolution of Radioimmunoscintigraphy for Imaging Prostate Cancer: Clinical Outcomes Data. Chapel Hill, NC.
University of North Carolina Department of Urology Grand Rounds. Advances in Diagnostic Imaging for Prostate Cancer: Clinical Outcomes Data. Chapel Hill, NC.
Washington University Department of Urology Grand Rounds. The Evolution of Immunoscintigraphy for Prostate Cancer. St. Louis, MO.
Owosso Memorial Hospital Grand Rounds. The Evolution of Immunoscintigraphy for Imaging Prostate Cancer. Owosso, MI.
Indiana Urological Association Annual Meeting. The Evolution of Immunoscintigraphy for Imaging Prostate Cancer. Indianapolis, IN.
Society of Nuclear Medicine Annual Meeting. The Utility of Prostascint in the Care of Prostate Cancer Patients. San Diego, CA.
Hartford Hospital Urological Update. The Role of Immunoscintigraphy for Imaging Prostate Cancer. Hartford, CT.
Masters in Urology Conference. The Future of Imaging for Prostate Cancer. Bermuda, UK.
Masters in Urology Conference. The Urologist and the Bright Side: Transition to the Corporate World. Bermuda, UK.
Masters in Urology Conference. Biomarkers for Bladder Cancer. Bermuda, UK.
Cytogen Training Seminar. The Basics of Prostate Cancer. Princeton, NJ.
3 national webcasts: The Role of Immunoscintigraphy in Imaging Prostate Cancer.
World Congress of Endourology. Molecular Imaging. Cleveland, OH.
World Congress of Endourology. Optical Coherence Tomography for Bladder Carcinoma. Cleveland, OH.
Duke University Department of Urology Grand Rounds. Searching for Prostate Cancer: The Evolution of Immunoscintigraphy. Durham, NC.
Urological Update. The Role of Immunoscintigraphy for Imaging Prostate Cancer. Raleigh, NC.
Urological Update. Searching for Prostate Cancer: the Role of Immunoscintigraphy for Imaging. Wilmington, NC.
West Virginia University Department of Urology Grand Rounds. Advances in Imaging for Prostate Cancer: Immunoscintigraphy. Morgantown, WV.
Stoney Brook University Department of Urology Grand Rounds. Searching for Prostate Cancer: The Evolution of Immunoscintigraphy. Stoney Brook, NY.
Stamford Hospital Tumor Board. The Evolution of Imaging for Prostate Cancer. Stamford, CT.
Urological Update. Advances in Diagnosis of Prostate Cancer: Imaging with Immunoscintigraphy. La Jolla, CA.
Workshop on Immunoscintigraphy. The Clinical Impact of Immunoscintigraphy for Detection of Prostate Cancer. Tampa, FL.
American Urological Association Mid-Atlantic Annual Meeting. The Evolution of Imaging for Prostate Cancer. Washington, DC.
Morristown Medical Center Tumor Board. Advances in Imaging for Prostate Cancer. Morristown, NJ.

2005

National Oncology Pharmacy Board. Advances in Management of Advanced Prostate Cancer. Phoenix, AZ.
Orlando Urologic Update. Advances in Imaging Prostate Cancer. Orlando, FL.
Philippine Medical Association Annual Meeting. Medical Management of Benign Prostatic Hyperplasia. Potomac, MD.
Atlanta Urologic Society. Advances in Diagnosis and Staging of Prostate Cancer. Atlanta, GA.
Emory University Grand Rounds. The Titanic Salvage Expedition: Remote Medical Care in the North Atlantic. Atlanta, GA.
American Urological Association Annual Meeting. Optical coherence tomography for superficial bladder cancer. Imalux Advisory Board and thre booth presentations. San Antonio, TX.
American Urological Association Annual Meeting. Plenary session Highlights: Prostate Cancer. San Antonio, TX.
Cook County Hospital Grand Rounds. Advances in Diagnosis and Imaging Urologic Cancer. Chicago, IL.
Amsterdam Medical Center Conference: Management of Benign Prostatic Hyperplasia. Minimally Invasive Thermal Therapies. Amsterdam, The Netherlands.
5th International Prostate Cancer Congress. Anti-PSMA Antibodies. San Juan, Puerto Rico.
Cytogen Corporation National Sales Meeting. Outcomes Data from Radioimmunoscintigraphy. Baltimore, MD.
World Congress of Endourology. Advances in Imaging Lymph Node Disease in Prostate Cancer. Amsterdam, The Netherlands.
Cytogen Corporation R & D Analyst Meeting. The Evolution of Radioimmunoscintigraphy. New York, NY.
NYU Urologic Grand Rounds. Advances in Diagnosis and Staging Prostate Cancer. New York, NY.
Minneapolis Urologic Society. The Evolution of Radioimmunoscintigraphy. Minneapolis, MN.
University of Pennsylvania Radiation Oncology Grand Rounds. Advances in Diagnosis and Staging Prostate Cancer. Philadelphia, PA.
Jacksonville Urological Update. The Evolution of Radioimmunoscintigraphy. Jacksonville, FL.
Halifax Hospital Grand Rounds. Advances in Diagnosis and Staging of Prostate Cancer. Daytona Beach, FL.
Methodist Hospital Grand Rounds. Radioimmunoscintigraphy for Prostate Cancer. Houston, TX.
3rd International Public Conference on Prostate Cancer. The Evolution of Radioimmunoscintigraphy. Industry Leadership Panel on Technology Transfer from Laboratory to Clinic. Washington, DC.
3rd International Public Conference on Prostate Cancer. The Role of Radioimmunoscintigraphy in Prostate Cancer Imaging. Clinical Management State of the Art. Washington, DC.

2004

Cytogen Corporation National Sales Meeting. Clinical Utility of ProstaScint: A Physician Perspective
3rd Annual Geriatric Symposium for Primary Care Providers. Benign Prostatic Hyperplasia: A Systematic Approach to Diagnosis and Treatment. Columbia, SC.
George Washington Hospital Community Symposium. Diagnosis and Treatment of Bladder Cancer. Washington, DC.
NASA Extreme Medicine Public Policy Workshop. Establishing Public Policy Guidelines. Tyson’s Corner, VA.
PriMed Update Conference. Diagnosis and Management of BPH. Baltimore, MD.
Atrix Technologies Roundtable Discussion on Androgen Ablation. Incremental Gains from Longer Acting Depot Agents. Denver, CO.
American Foundation for Urologic Disease (AFUD) annual fundraiser.Advances in Prostate Cancer. Reston, VA.
Director, National Urology Residents and Fellows Forum of Excellence.Advances in Urologic Cancer Imaging. San Francisco, CA.
IUN Urological Update. Advances in Diagnosis and Treatment of Prostate Cancer. Saddlebrook, NJ.
Director of four national teleconferences on management of BPH. Sanofi Pharmaceuticals.
Director of three national teleconferences on management of advanced prostate cancer. Sanofi Pharmaceuticals.
Pennsylvania Urological Society Update. Management of Benign Prostatic Hyperplasia. York, PA.
IUN Urological Update. Advances in Diagnosis and Treatment of Prostate Cancer. New York, NY.
Columbia Medical Update. Management of Benign Prostatic Hyperplasia. Columbia, SC.
GW Institute of Biomedical Engineering Symposium. Medical Imaging. Washington, DC.
4th International Prostate Cancer Congress. An Update in Prostate Cancer Imaging. Bahamas.
University of the East Annual Alumni Medical Conference. Prostate Cancer: Advances in Diagnosis and Treatment. Chicago. IL.
Grand Rounds Wincester, VA. Medical and Surgical Management of Benign Prostatic Hyperplasia. Winchester, VA.
HP Environmental, Inc., Annual Meeting. Diving the Titanic: Tales of Medicine from the North Atlantic. Beckley, WV.
The GW Cancer Institute Cancer Disparities Conference Series. Prostate Cancer Disparities: Science, Health Care, and Public Policy. Washington, DC.
Urological Update. Medical Management of Benign Prostatic Hyperplasia. Bethesda, MD.
The Explorers Club Philadelphia Chapter Symposium on Underwater Salvage. Strategies for Health Care on Expeditions to Remote Locations: The Titanic Experience. Philadelphia, PA.
PriMed Update Conference. Diagnosis and Management of BPH. Phoenix, AZ.
Epidemiology of Transportation Systems and Bioterrorism Workshop. School of Public Policy, George Mason University. Workshop participant on medical issues. Burke, VA.
World Congress of Endourology. Evaluation of Superficial Bladder Cancer by Optical Coherence Tomography. Mumbai, India.
Washington Academy of Biomedical Engineering. Geometrical and Physical Models in Medical Image Anaylysis: Fundamentals and Clinical Applications. Clinical Application of Image Analysis. Washington, DC.
American Urological Association Prostate Cancer Course. Cryotherapy for Prostate Cancer. Washington, DC.
American Urological Association Prostate Cancer Course. Advances in Imaging for Prostate Cancer. Washington, DC.
American Urological Association Prostate Cancer Course. The Titanic Salvage Expedition. Washington, DC.